Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation for Depression
Study Summary
This trial is testing a new type of transcranial magnetic stimulation to see if it reduces suicidal thoughts in adolescents with depression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with major depression according to DSM-5.I am either female or male.I am experiencing severe depression and have thoughts of harming myself.I have been experiencing depression for more than 4 weeks but less than 3 years.You have metal implants in your head, like cochlear implants or brain stimulators, that cannot be safely removed and are within 30 cm of the treatment coil.I am between 12 and 18 years old.I meet the safety requirements for TMS treatment.I may be taking antidepressants as advised by my doctor and agreed by my parents and me.You have been diagnosed with certain mental health conditions like psychosis, bipolar disorder, severe eating disorders, or substance abuse issues in the past year (except for caffeine and tobacco).I, or my guardian, can legally agree to treatment.You have taken any experimental medication within the last 4 weeks.I have undergone electroconvulsive therapy or TMS.I am at risk for high pressure in my brain due to a tumor.I have had brain surgery before.I have a history of seizures.I have had a head injury that made me lose consciousness.I have a family history of epilepsy.You have a medical condition that is not stable or under control.
- Group 1: Sham seqential billateral accelerated theta burst stimulation
- Group 2: Sequential bilateral accelerated theta burst stimulation
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the total number of participants involved in this experiment?
"Affirmative, the information hosted on clinicaltrials.gov implies that enrolment for this medical trial is ongoing. Initial posting date was April 4th 2022 and it was last amended on July 8th 2022. This investigation requires 80 participants from a single site to complete their study."
Is enrollment for this research open to the public?
"This clinical trial needs 80 volunteers aged 12 to 18, currently struggling with suicidal ideation. In addition to this primary criterion, the patient must meet additional conditions such as inpatient or outpatient status and a certain level of depressive symptom severity demonstrated by CDRS-R total composite score. Furthermore, they should be female or male experiencing MDD for at least 4 weeks but less than 3 years; their symptoms should have not improved between screening and baseline visits by 25% or more; they need to eligible for transcranial magnetic stimulation (TMS) based on safety criteria104; finally, they must also fit DSM-5 diagnostic criteria122 with"
Is the minimum age for participation in this experiment set at 18 years or younger?
"The criteria for enrolment in this trial necessitates that applicants are between 12 and 18 years old. There are currently 211 trials recruiting patients younger than 18, whereas 1005 are looking to recruit those over 65."
Is recruitment still ongoing for this clinical experiment?
"According to clinicaltrials.gov, this particular medical trial is open for enrollment. The initial post was made on April 4th 2022 and the most recent edit occurred July 8th of that same year."
Share this study with friends
Copy Link
Messenger